Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2641 | Adaptimmune Therapeutics PLC (473A.DU) | XDUS | GB | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2642 | Adaptimmune Therapeutics PLC (473A.F) | XFRA | GB | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2643 | Adaptimmune Therapeutics PLC (473A.MU) | XMUN | GB | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2644 | Adaptimmune Therapeutics PLC (473A.SG) | XSTU | GB | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2645 | Adaptimmune Therapeutics PLC (473A.SW) | XSWX | GB | 2023-12-31 | 3 weeks ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2646 | Adaptimmune Therapeutics PLC (473A.TG) | XGAT | GB | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2647 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2023-12-31 | 1 day ago | USD | 1.14 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2648 | Adaptive Biotechnologies Corp (1HM.BE) | XBER | US | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.40 | 0.00% | Ungraded | 0.00 | 0.00% |
| 2649 | Adaptive Biotechnologies Corp (1HM.DE) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.59 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 2650 | Adaptive Biotechnologies Corp (1HM.DU) | XDUS | US | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.40 | 0.00% | Ungraded | 0.00 | 0.00% |